Harmony of two bacteria opens new path in cancer treatment
Medical Xpress - 05-Aug-2025New dual-bacteria therapy shows potent, safe cancer-killing power in immunocompromised models
The Live Forever Club is evolving. Subscribe to the newsletter to be the first to hear about this important change.
Pharmaceutical company
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 2,305.4 billion in revenue in 2018.
Visit website: https://www.daiichisankyo.com/
Details last updated 31-Jul-2020
New dual-bacteria therapy shows potent, safe cancer-killing power in immunocompromised models
New drug could become the best one to target and treat multiple tumours in the future